GB1194912A - Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin - Google Patents

Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin

Info

Publication number
GB1194912A
GB1194912A GB2718967A GB2718967A GB1194912A GB 1194912 A GB1194912 A GB 1194912A GB 2718967 A GB2718967 A GB 2718967A GB 2718967 A GB2718967 A GB 2718967A GB 1194912 A GB1194912 A GB 1194912A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
treatment
skin
compositions suitable
physiological disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2718967A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MINI IND CHIMICE
Original Assignee
MINI IND CHIMICE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MINI IND CHIMICE filed Critical MINI IND CHIMICE
Publication of GB1194912A publication Critical patent/GB1194912A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,194,912. Pharmaceutical compositions. RUMANIA, MINISTRY OF INDUSTRIAL CHEMICALS. 13 June, 1967 [12 Sept., 1966], No. 27189/67. Heading A5B. Pharmaceutical compositions for use in cicatrization processes and the treatment of skin diseases comprise cysteine, homocysteine or thiazolidine-4-carboxylic acid admixed with calcium sulphosalicylate, lithium sulphosalicylate and folic acid and at least one known pharmaceutical unguent base.
GB2718967A 1966-09-12 1967-06-13 Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin Expired GB1194912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO5215766 1966-09-12

Publications (1)

Publication Number Publication Date
GB1194912A true GB1194912A (en) 1970-06-17

Family

ID=20086543

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2718967A Expired GB1194912A (en) 1966-09-12 1967-06-13 Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin

Country Status (7)

Country Link
AT (1) AT290718B (en)
BE (1) BE700252A (en)
BR (1) BR6791453D0 (en)
CH (1) CH481650A (en)
DE (1) DE1617639A1 (en)
GB (1) GB1194912A (en)
NL (1) NL6709276A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1886676A1 (en) * 2006-08-09 2008-02-13 Polichem S.A. Compositions with enhanced elasticizing activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1886676A1 (en) * 2006-08-09 2008-02-13 Polichem S.A. Compositions with enhanced elasticizing activity
JP2010500309A (en) * 2006-08-09 2010-01-07 ポリケム・エスエイ Composition having high elasticity-imparting activity

Also Published As

Publication number Publication date
BE700252A (en) 1967-12-01
NL6709276A (en) 1968-03-13
BR6791453D0 (en) 1973-02-22
CH481650A (en) 1969-11-30
AT290718B (en) 1971-06-11
DE1617639A1 (en) 1972-04-20

Similar Documents

Publication Publication Date Title
NO1994018I1 (en) Mometasone furoate
NL7607338A (en) PROCESS FOR THE PREPARATION OF 1,4-DIHYDROPYRINE DERIVATIVES WITH VASOLICULATING AND BLOOD PRESSURE-REDUCING ACTIVITY.
NL182279B (en) ABSORBENT PRODUCTION AND COMPOSITION USED IN THE MANUFACTURE OF SUCH PRODUCT.
FI51190C (en) Process for the preparation of therapeutically active, in particular N- (3,4,5-trimethoxy-cinnamoyl) -piperazine derivatives of the coronadilator.
IT7928417A0 (en) PHARMACEUTICAL COMPOSITIONS WITH EXALTATION OF THE THERAPEUTIC ACTIVITY OF CORTISONICS.
ES474493A1 (en) Substituted mercapto acid amides, process for their preparation, pharmaceutical composition containing same and their use.
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
IT1052282B (en) COMPOSITION FOR THE TREATMENT OF ACNE
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
FR2261M (en) Preventive and curative drug for various skin diseases.
GB1194912A (en) Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin
AU454611B2 (en) Thienyl-fattyacid derivatives processes for their production, and their use as therapeutic agents
CA944688A (en) Certain diphenyl sulfones in the treatment of marek's disease
JPS522433A (en) Single bath color element silver branching liquid
AU458749B2 (en) Process for the treatment and care of dentures
IE811612L (en) Thiazoles
IL37729A0 (en) Cycloaliphatic difunctional nitrogen-containing sulphonic acid esters,their manufacture and their use as medicines
AU2461871A (en) Pharmaceutical compositions useful in the treatment of involuntary movement disorders
GB1327466A (en) Pharmaceutical compositions for inhibiting indoleamine-n- methyl transferase
SE8802323L (en) 8ALFA-ACYLAMINOERGOLIN, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR1162M (en) Medicinal product applicable in the therapy of hypertension.
FR3183M (en) Medicinal product exhibiting vitamin b6 activity and which can be used in particular against diseases of the epidermis and dermis, based on di-acyl-3,4-pyridoxines.
FI51344C (en) Process for the preparation of anti-fibrinolytically active 4-aminomethylbicyclo [2.2.1] heptane-1-carboxylic acid
AU262608B2 (en) Therapeutic composition comprising 3, - diethyl - 5 - methyl - 2,4 - piperidinedione and 7 - chloro - 2- methylamino - 5- phenyl - 3h - 1,4 - benzodiazepine - 4- oxide or its acid salt
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees